Dr. Russell Blaylock, author of The Blaylock Wellness Report newsletter, is a nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer. He attended the Louisiana State University School of Medicine and completed his internship and neurological residency at the Medical University of South Carolina. For 26 years, practiced neurosurgery in addition to having a nutritional practice. He recently retired from his neurosurgical duties to devote his full attention to nutritional research. Dr. Blaylock has authored four books, Excitotoxins: The Taste That Kills, Health and Nutrition Secrets That Can Save Your Life, Natural Strategies for Cancer Patients, and his most recent work, Cellular and Molecular Biology of Autism Spectrum Disorders. Find out what others are saying about Dr. Blaylock by clicking here.

Reduce Prostate Inflammation

Thursday, 03 January 2013 08:37 AM

There is growing evidence that a common condition in men, benign prostate hypertrophy (BPH), is actually an immune disorder gone awry.
Approximately 50 percent of men over the age of 70 develop BPH, which is also called an enlarged prostate. This condition can lead to frequent urination (especially at night) and an eventual need for surgical treatment.
In a recent study published in the Journal of Immunology, researchers biopsied the prostate glands of five men suffering from typical prostate enlargement. The researchers found that all five demonstrated prostate inflammation, which seemed to originate from special cells called stromal cells.
For as yet unknown reasons, these cells began to produce high levels of cell-signaling molecules called inflammatory cytokines (Il-6, IL-1ß, and TNF-alpha). These acted like growth factors and stimulated the prostate gland to produce too many cells. This explains the enlargement of the gland. (For a detailed discussion on inflammation and its role in many diseases, see my newsletter "Inflammation: The Real Cause of Most Diseases." )
Another factor that is produced, IL-8, stimulates an even greater release of other growth factors, keeping the gland enlarged and inflamed. In addition, IL-8 attracts other immune cells, such as T-cells, macrophages, and neutraphils, which also help to keep the gland inflamed.
Other studies have also shown that high levels of IL-8 and IL-6 in the blood make excellent markers for predicting the course of BPH, as well as predicting the risk of developing prostate cancer. In fact, men with prostate cancer who have high levels of IL-6 have a worse prognosis.
This study gives rise to several important questions. For example, what initiates the inflammation in the prostate? Is it bacteria, a fungus, or a virus? In a number of cases, there is a link to all three. Or it may just represent an autoimmune disease that is caused by damage to the immune system.
Another question is: What can be done to reduce the inflammation? Interestingly, the same cells that produce the inflammation also contain a number of vitamin D3 receptors. High-dose vitamin D3 — around 5,000 to 10,000 IU a day — may be able to block the inflammation and growth factors. To learn more about vitamin D3, read my special report "Vitamin D's Hidden Role in Your Health."
Curcumin, quercetin, natural vitamin E, resveratrol, silymarin, magnesium, lycopene, indole-3 carbinol, and ellagic acid also reduce inflammation in the prostate and are known to inhibit cancer development and growth. This would be far more effective and more science-based than the drugs currently being used.
For more of Dr. Blaylock’s weekly tips, go here to view the archive.

© HealthDay

1Like our page
Thursday, 03 January 2013 08:37 AM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved